THE FEDERAL Government has announced lenalidomide (Revlimid) will be added to the Pharmaceutical Benefits Scheme (PBS) from 1 November 2009.
13/10/2009
AS OF the 1 September 2009, patients treating their HIV with antiretroviral medication life is set to improve with the Pharmaceutical Benefits Scheme (PBS) listing of a therapy which helps correct HIV-associated facial lipoatrophy (facial fat loss).
04/09/2009
THE LIFE Technologies Foundation, a non-profit arm of Life Technologies has awarded approximately $1.7 million in new grants which include the creation of an online biology textbook, and building a museum exhibit about the human cell.
02/10/2009
AMSBIO has announced the release of its FACSmax cell dissociation solution. FACSmax has been developed from a proprietary formulation of proteolytic, collagenolytic and DNAse enzymes.
Road Freight News
Clinical Lab
Medical Devices Equipment
Submit your content to Life Science Lab
This site is an essential online source of information and a community where life science professionals interact.